Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30 [Turk J Hematol]
Turk J Hematol. 2017; 34(2): 197-199 | DOI: 10.4274/tjh.2016.0409  

Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30

Mehmet Can Uğur1, Yaşar Bekir Kutbay2, Özge Özer Kaya2, Cengiz Ceylan3
1Tepecik Training and Research Hospital, Clinic of Internal Medicine, İzmir, Turkey
2Tepecik Training and Research Hospital, Genetic Diagnostic Center, İzmir, Turkey
3Tepecik Training and Research Hospital, Clinic of Hematology, İzmir, Turkey

Keywords: Cytogenetic, Chronic myeloid leukemia, Molecular hematology, Life-quality, Dasatinib, Nilotinib


Kronik Miyeloid Lösemili Hastaların Yaşam Kalitesinin EORTC QLQ-C30 Anketi Kullanılarak Değerlendirilmesi

Mehmet Can Uğur1, Yaşar Bekir Kutbay2, Özge Özer Kaya2, Cengiz Ceylan3
1Tepecik Training and Research Hospital, Clinic of Internal Medicine, İzmir, Turkey
2Tepecik Training and Research Hospital, Genetic Diagnostic Center, İzmir, Turkey
3Tepecik Training and Research Hospital, Clinic of Hematology, İzmir, Turkey

Anahtar Kelimeler: Sitogenetik, Kronik miyeloid lösemi, Moleküler hematoloji, Yaşam kalitesi, Dasatinib, Nilotinib


Mehmet Can Uğur, Yaşar Bekir Kutbay, Özge Özer Kaya, Cengiz Ceylan. Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30. Turk J Hematol. 2017; 34(2): 197-199

Corresponding Author: Mehmet Can Uğur, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2015) = 0.827